California Public Employees Retirement System’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-8,540
Closed -$639K 3012
2021
Q1
$639K Sell
8,540
-786
-8% -$81.7K ﹤0.01% 2808
2020
Q4
$1.01M Buy
9,326
+321
+4% +$29.3K ﹤0.01% 2463
2020
Q3
$796K Sell
9,005
-464
-5% -$52.7K ﹤0.01% 2448
2020
Q2
$1.01M Buy
9,469
+5,969
+171% +$536K ﹤0.01% 2236
2020
Q1
$208K Buy
3,500
+630
+22% +$42.7K ﹤0.01% 2837
2019
Q4
$198K Buy
+2,870
New +$174K ﹤0.01% 3108

Other funds holding SYRS

California Public Employees Retirement System's SYRS Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2021, closing a stake of 8,540 shares — an estimated $639K sold.

California Public Employees Retirement System first reported a position in SYRS in Q4 2019 and held it in 6 quarters. The position peaked at $1.01M in Q4 2020. 100 funds tracked by Wall St. Rank hold SYRS as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 8,540 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $639K.
  • California Public Employees Retirement System first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • California Public Employees Retirement System's Syros Pharmaceuticals, Inc. Common Stock position peaked at $1.01M in Q4 2020.
  • 100 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.